Abstract
Background It is generally recognized that Parkinson’s disease (PD) affects males more commonly than females. The reasons for the difference in PD prevalence by gender remain unclear.
Methods In this systematic review and meta-analysis, we updated previous work by searching MEDLINE, SCOPUS, and OVID for articles reporting PD prevalence for both genders between 2011-2021. We calculated overall male/female prevalence ratios (OPR) and investigated heterogeneity in effect estimates.
Results 19 new and 13 previous articles were included. The OPR was 1.18, 95% CI [1.03, 1.36]. The OPR was lowest in Asia and appeared to be decreasing over time. Study design, national wealth, and participant age did not explain heterogeneity in OPR.
Conclusion Gender differences in PD prevalence may not be as stark as previously thought, but still remain. Studies are needed to understand the role of genetic, environmental, and societal determinants of gender differences in prevalence.
Competing Interest Statement
A.J.N. reports grants from the Barts Charity, Parkinson’s UK, Aligning Science Across Parkinson’s and Michael J. Fox Foundation, and the Virginia Keiley Benefaction. Personal fees/honoraria from Britannia, BIAL, AbbVie, Global Kinetics Corporation, Profile, Biogen, Roche, and UCB are outside of the submitted work. I.F.M. reports grants from Aligning Science Across Parkinson’s and Michael J. Fox Foundation, The Parkinsons Foundation, American Parkinson Disease Association, and National Institutes of Health.
Funding Statement
A.J.N. reports grants from the Barts Charity, Parkinson’s UK, Aligning Science Across Parkinson’s and Michael J. Fox Foundation, and the Virginia Keiley Benefaction. Personal fees/honoraria from Britannia, BIAL, AbbVie, Global Kinetics Corporation, Profile, Biogen, Roche, and UCB are outside of the submitted work. I.F.M. reports grants from Aligning Science Across Parkinson’s and Michael J. Fox Foundation, The Parkinsons Foundation, American Parkinson Disease Association, and National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We have used published articles on prevalence of PD in both genders. The references are available in the file "Prevalence v5.pdf" (see supplementary material).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Joint first authors
Relevant conflicts of interest/financial disclosures: Nothing to report.
Funding sources: A.J.N. reports grants from the Barts Charity, Parkinson’s UK, Aligning Science Across Parkinson’s and Michael J. Fox Foundation, and the Virginia Keiley Benefaction. Personal fees/honoraria from Britannia, BIAL, AbbVie, Global Kinetics Corporation, Profile, Biogen, Roche, and UCB are outside of the submitted work. I.F.M. reports grants from Aligning Science Across Parkinson’s and Michael J. Fox Foundation, The Parkinson’s Foundation, American Parkinson Disease Association, and National Institutes of Health.
Data Availability
All data produced in the present work are contained in the manuscript and supplementary files.
